Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
Xenon to Report Q1 2025 Financial Results on May 12, 2025
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)